Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000578557 | SCV000680893 | uncertain significance | not provided | 2016-10-17 | criteria provided, single submitter | clinical testing | The R516X variant in the FLVCR1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function through protein truncation. The R516X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R516X as a variant of uncertain significance. |
Mendelics | RCV000986511 | SCV001135526 | pathogenic | Posterior column ataxia-retinitis pigmentosa syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000578557 | SCV002164773 | pathogenic | not provided | 2023-08-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg516*) in the FLVCR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLVCR1 are known to be pathogenic (PMID: 23591405, 27923065). This variant is present in population databases (rs538343832, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FLVCR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 488940). For these reasons, this variant has been classified as Pathogenic. |